Glaxo set for big push into cancer medicine
(Reuters)


Reuters - GlaxoSmithKline Plc is preparing for a
"renaissance" of its oncology business, led by Tykerb, a novel
pill that is expected to win U.S. regulatory approval for
breast cancer next month.